Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 1 December 2008

Thorax. Published Online First: 22 August 2008. doi:10.1136/thx.2007.094706
Copyright © 2008 BMJ Publishing Group Ltd & British Thoracic Society.

Papers

Management of acute bronchiolitis: Can evidence-based guidelines alter clinical practice?

Juerg Barben 1*, Claudia Elisabeth Kuehni 2, Daniel Trachsel 3 and Juerg Hammer 3

1 Ostschweizer Kinderspital, Switzerland
2 University of Bern, Switzerland
3 University Childrens' Hospital Basel, Switzerland

* To whom correspondence should be addressed. E-mail: juerg.barben{at}kispisg.ch.

Accepted 22 July 2008


Abstract

Background: Acute bronchiolitis is the most common lower respiratory tract infection in infants and there is no evidence that drug treatment alters its natural course. Despite this, most Swiss paediatricians reported in 2001 to prescribe bronchodilators and inhaled corticosteroids (ICS). This situation led to the creation of national guidelines followed by a tailored implementation program. The aim of this study was to examine if treatment practices changed after the implementation of the new guidelines.

Methods: We sent a questionnaire on treatment of bronchiolitis to all Swiss paediatricians before (2001) and after (2006) creation and implementation of national guidelines (2003-2005). Guidelines were created in collaboration between all paediatric pulmonologists and implemented carefully using a multifaceted approach.

Results: Questionnaires were returned by 541 paediatricians (58%) in 2001, and 639 (54%) in 2006. While both surveys showed a wide variation in the treatment of bronchiolitis between physicians, reported drug prescription decreased significantly between the two surveys. For outpatients, general use (for all patients) of bronchodilators dropped from 60% to 23%, and general use of ICS from 34% to 6%. For inpatients, general use of bronchodilators and ICS dropped from 55% to 18% and from 26% to 6% respectively (all p <0.001). The decrease was evident in all regions, among hospital and primary care physicians, and among general paediatricians and paediatric pulmonologists.

Conclusions: National guidelines together with a tailored implementation program can have a major impact on medical management practices in a country.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Lenney, W., Boner, A. L., Bont, L., Bush, A., Carlsen, K-H., Eber, E., Fauroux, B., Gotz, M., Greenough, A., Grigg, J., Hull, J., Kimpen, J., Sanchez Luna, M., de Benedictis, F. M. (2009). Medicines used in respiratory diseases only seen in children. Eur Respir J 34: 531-551 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Chest Medicine Jobs

Chest Medicine Jobs